Market Overview

26 Stocks Moving In Tuesday's Pre-Market Session

Share:

Gainers

  • Gevo, Inc. (NASDAQ: GEVO) rose 25 percent to $5.50 in pre-market trading after gaining 12.53 percent on Monday.
  • Pacific Ethanol, Inc. (NASDAQ: PEIX) shares rose 21.6 percent to $3.27 in pre-market trading after climbing 43.09 percent on Monday.
  • Pyxus International, Inc. (NYSE: PYX) rose 19 percent to $45.80 in pre-market trading after surging 36.69 percent on Monday
  • Youngevity International, Inc. (NASDAQ: YGYI) rose 16.2 percent to $7.11 in pre-market trading after falling 15.82 percent on Monday.
  • Centrais Elétricas Brasileiras S.A. - Eletrobras (NYSE: EBR) rose 10.9 percent to $6.50 in pre-market trading after gaining 20.58 percent on Monday.
  • Papa John's International, Inc. (NASDAQ: PZZA) rose 8.9 percent to $54.90 in pre-market trading following The Wall Street Journal report that Trian is in early stages of evaluating a bid for Papa John's.
  • ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) shares rose 7.4 percent to $3.06 in pre-market trading after reporting a new license agreement with Intrexon Corporation.
  • VAALCO Energy, Inc. (NYSE: EGY) rose 6 percent to $2.68 in pre-market trading.
  • PDL BioPharma, Inc. (NASDAQ: PDLI) rose 5.7 percent to $2.79 in pre-market trading.
  • Francesca's Holdings Corporation (NASDAQ: FRAN) rose 4.8 percent to $3.71 in pre-market trading after dropping 3.01 percent on Monday.
  • Helen of Troy Limited (NASDAQ: HELE) rose 4.3 percent to $128.00 in pre-market trading after the company reported upbeat results for its second quarter and raised its FY19 guidance.
  • Tower Semiconductor Ltd. (NASDAQ: TSEM) rose 3.7 percent to $20.73 in pre-market trading. TowerJazz is expected to report its Q3 earnings on Monday, October 29, 2018.
  • Frontline Ltd. (NYSE: FRO) rose 3 percent to $6.54 in pre-market trading after falling 2.16 percent on Monday.

 

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Affimed N.V. (NASDAQ: AFMD) shares fell 25.5 percent to $3.45 in pre-market trading after the company reported a clinical hold on AMF11 following serious adverse events in three patients, including one death and two life-threatening events.
  • Blackbaud, Inc. (NASDAQ: BLKB) shares fell 19.6 percent to $72.50 in pre-market trading after the company lowered its FY18 earnings and sales guidance.
  • India Globalization Capital, Inc. (NYSE: IGC) fell 13.6 percent to $5.80 in pre-market trading after gaining 66.42 percent to Monday.
  • Tata Motors Limited (NYSE: TTM) shares fell 14 percent to $12.35 in pre-market trading.
  • PPG Industries, Inc. (NYSE: PPG) shares fell 9.7 percent to $98.98 in pre-market trading after the company issued weak forecast for the third quarter.
  • Clean Energy Fuels Corp. (NASDAQ: CLNE) fell 8.1 percent to $2.28 in pre-market trading.
  • New Age Beverages Corporation (NASDAQ: NBEV) fell 5.6 percent to $6.98 in pre-market trading after dropping 12.75 percent on Monday.
  • Nielsen Holdings plc (NYSE: NLSN) shares fell 5.4 percent to $25.45 in pre-market.
  • ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) fell 4.8 percent to $20.09 in pre-market trading.
  • Halozyme Therapeutics, Inc. (NASDAQ: HALO) shares fell 4.6 percent to $16.73 in pre-market trading after dropping 4.26 percent on Monday.
  • B2Gold Corp. (NYSE: BTG) fell 4.4 percent to $2.41 in pre-market trading after rising 3.28 percent on Monday.
  • Astrotech Corporation (NASDAQ: ASTC) fell 4.3 percent to $2.25 in pre-market trading after dropping 9.96 percent on Monday.
  • Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) fell 4.1 percent to $2.35 in pre-market trading.

Posted-In: #PreMarket GainersNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

 

Related Articles (ACAD + AFMD)

View Comments and Join the Discussion!

Easy As ACB? Another Cannabis Company To List On The NYSE

The Daily Biotech Pulse: Affimed's Cancer Drug Placed On Clinical Hold, Celgene's Positive Scalp Psoriasis Trial